Semler Scientific, Inc. (SMLR)
$
40.08
-1.24 (-3.09%)
Key metrics
Financial statements
Free cash flow per share
-18.0064
Market cap
455.9 Million
Price to sales ratio
9.2611
Debt to equity
0.5943
Current ratio
0.5173
Income quality
-0.5650
Average inventory
364 Thousand
ROE
-0.2149
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company earned an interest income of $1,877,000.00 showcasing its financial investments. Moreover, it recorded a net income of $40,899,000.00 reflecting its profitability within a competitive market. The company's stock is identified with the symbol '$SMLR' in the market, a testament to its presence among public investors. With a focus on its niche markets, the company achieved a revenue of $56,294,000.00 indicating its targeted approach to the healthcare sector. Additionally, the income before tax ratio is $0.85 reflecting the pre-tax margin that underscores its operational efficiency. Semler's innovative products, including QuantaFlo, empower healthcare providers by facilitating quick and effective assessments of vascular conditions, catering to specialists across various medical fields such as cardiology, nephrology, and more. Within the investment landscape, the stock is reasonably priced at $40.08 appealing to a broad range of investors. Coupled with an average trading volume of 635,825.00 the stock indicates moderate liquidity, enhancing its attractiveness for trading. With a market capitalization of $446,956,128.00 the company is classified as a small-cap player, which often allows for significant growth opportunities. Semler Scientific, Inc. stands out as a key player in the Medical - Devices industry, contributing significantly to the overall market landscape through its innovative solutions. It belongs to the Healthcare sector, driving innovation and growth, thereby making a notable impact on the healthcare ecosystem and the delivery of clinical services across the United States.
Is Semler Scientific, Inc. (SMLR) a good investment?
Investing in Semler Scientific, Inc. (SMLR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Semler Scientific, Inc. (SMLR)'s stock forecast?
Analysts predict Semler Scientific, Inc. stock to fluctuate between $21.77 (low) and $81.56 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Semler Scientific, Inc.'s market capitalization?
As of 2025-05-29, Semler Scientific, Inc.'s market cap is $446,956,128, based on 11,151,600 outstanding shares.
How does Semler Scientific, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Semler Scientific, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Semler Scientific, Inc. (SMLR) stock?
To buy Semler Scientific, Inc. (SMLR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SMLR. Place an order (Market, Limit, etc.).
What is the best time to invest in Semler Scientific, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Semler Scientific, Inc. perform in the last earnings report?
Revenue: $56,294,000 | EPS: $5.66 | Growth: 84.97%.
Where can I find Semler Scientific, Inc.'s investor relations reports?
Visit https://www.semlerscientific.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Semler Scientific, Inc.?
You can explore historical data from here
What is the all-time high and low for Semler Scientific, Inc. stock?
All-time high: $153.21 (2021-10-29) | All-time low: $19.12 (2023-03-17).
What are the key trends affecting Semler Scientific, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. So What: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a cont.
globenewswire.com
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
businesswire.com
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SEMLER SCIENTIFIC INC. (SMLR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SEMLER SCIENTIFIC INC. (SMLR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SEMLER SCIENTIFIC INC. (SMLR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On February 28, 2025, Semler filed its annual report for ful.
globenewswire.com
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) on behalf of Semler stockholders. Our investigation concerns whether Semler has violated the federal securities laws and/or engaged in other unlawful business practices.
prnewswire.com
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , May 19, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces its investigation of potential breaches of fiduciary duty by the Board of Directors and senior management of Semler Scientific Inc. (NASDAQ: SMLR) ("Semler" or the "Company"). The investigation concerns whether and certain of its officers and/or directors have engaged in securities fraud.
seekingalpha.com
Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2025 Earnings Conference Call May 13, 2025 4:00 PM ET Company Participants Doug Murphy-Chutorian - CEO Eric Semler - Chairman Jennifer Oliva Herrington - COO Renae Cormier - CFO Operator Good afternoon and welcome to the Semler Scientific First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.
businesswire.com
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Semler Scientific, Inc. (“Semler”) (NASDAQ: SMLR) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/semler-scientific/ The investigation seeks to determine whether Semler and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions. Semler s.
See all news
